Ubiquitination/ Proteasome
Research Areas
Products Related to Ubiquitination/ Proteasome(1361)
- GC52447Suc-Leu-Leu-Val-Tyr-AMC (trifluoroacetate salt)Purity: >98.00%
A fluorogenic substrate for the 20S proteasome and calpains
- GC60076BigelovinCAS: 3668-14-2Purity: >99.50%
Bigelovin, a sesquiterpene lactone isolated from Inula helianthus-aquatica, is a selective retinoid X receptor α agonist. Bigelovin suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation.
- GC60159Ezetimibe ketoneCAS: 191330-56-0Purity: >98%
Ezetimibe ketone (EZM-K) is a phase-I metabolite of Ezetimibe.
- GC60241Melatonin D5CAS: 66521-38-8Purity: >98%
An internal standard for the quantification of melatonin
- GC60257MSC1094308CAS: 2219320-08-6Purity: >98.00%
MSC1094308 is a non-competitive and reversible VPS4B/p97 (VCP) (I/II type AAA ATPase) allosteric inhibitor, with IC50 values of 0.71 μM and 7.2 μM for VPS4B and p97, respectively. MSC1094308 inhibits the D2 ATPase activity by binding to a drugable hotspot of p97. MSC1094308 can be used in study of cancer.
- GC60395(3S,5R)-Fluvastatin D6CAS: 2249799-34-4Purity: >98%
(3S,5R)-Fluvastatin D6 is the deuterium labeled (3S,5R)-Fluvastatin sodium.
- GC60567Afatinib impurity 11CAS: 1402086-20-7Purity: >99.00%
Afatinib impurity 11 is an impurity of Afatinib. Afatinib is an irreversible EGFR family inhibitor with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively.
- GC60668Calcimycin hemimagnesiumCAS: 72124-77-7Purity: >98%
Calcimycin (A-23187) hemimagnesium is an antibiotic and a unique divalent cation ionophore (like calcium and magnesium).
- GC60688Cereblon modulator 1CAS: 1860875-51-9Purity: >99.50%
Cereblon modulator 1 (CC-90009) is a first-in-class GSPT1-selective cereblon (CRBN) E3 ligase modulator, acts as a molecular glue.
- GC60826Etoposide phosphateCAS: 117091-64-2Purity: >96.00%
Etoposide phosphate (BMY-40481) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor?to prevent re-ligation of DNA strands.
- GC60868Gefitinib D8CAS: 857091-32-8Purity: >98.00%
Gefitinib D8 (ZD1839 D8) is a deuterium labeled Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells.
- GC60891GW406108XCAS: 1644443-92-4Purity: >98.00%
GW406108X is a specific Kif15 (Kinesin-12) inhibitor with an IC50 of 0.82 uM in ATPase assays. GW406108X, a potent autophagy inhibitor, shows ATP competitive inhibition against ULK1 with a pIC50 of 6.37 (427 nM). GW406108X inhibits ULK1 kinase activity and blocks autophagic flux, without affecting the upstream signaling kinases mTORC1 and AMPK.
- GC60930Imatinib D4CAS: 1134803-16-9Purity: >98%
Imatinib D4 (STI571 D4) is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity.
- GC60935Indomethacin sodium hydrateCAS: 74252-25-8Purity: >98.00%
Indomethacin (Indometacin) sodium hydrateis a potent, orally active COX1/2 inhibitor with IC50 values of 18 nM and 26 nM for COX-1 and COX-2, respectively.
- GC61003Loperamide D6 hydrochlorideCAS: 1189469-46-2Purity: >98%
Loperamide D6 hydrochloride (R-18553 D6 hydrochloride) is a deuterium labeled Loperamide hydrochloride.
- GC61045Metformin D6 hydrochlorideCAS: 1185166-01-1Purity: >98.00%
An internal standard for the quantification of metformin
- GC61155Omeprazole sodiumCAS: 95510-70-6Purity: >98.00%
Omeprazole sodium (H 16868 sodium), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders.
- GC61183Physalin BCAS: 23133-56-4Purity: >98%
Physalin B, one of the major active steroidal constituents of Cape gooseberry, induces cell cycle arrest and triggers apoptosis in breast cancer cells through modulating p53-dependent apoptotic pathway. Physalin B inhibits the ubiquitin-proteasome pathway and induces incomplete autophagic response in human colon cancer cells in vitro.
- GC61221PTP1B-IN-9CAS: 145888-79-5Purity: >98.00%
PTP1B-IN-9 is a ubiquitin-proteasome system (UPS)-stressor. PTP1B-IN-9 inhibits ubiquitin-mediated protein degradation upstream of the 20S proteasomal catalytic activites. PTP1B-IN-9 triggers a ubiquitin-proteasome-system (UPS)-stress response without affecting 20S proteasome catalytic activities. Anticancer activity.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC52447 | Suc-Leu-Leu-Val-Tyr-AMC (trifluoroacetate salt) | - | >98.00% | |
A fluorogenic substrate for the 20S proteasome and calpains | ||||
| GC52477 | Corynoxine (hydrochloride) | - | >98.00% | |
An indole alkaloid | ||||
| GC60076 | Bigelovin | 3668-14-2 | >99.50% | |
Bigelovin, a sesquiterpene lactone isolated from Inula helianthus-aquatica, is a selective retinoid X receptor α agonist. Bigelovin suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation. | ||||
| GC60159 | Ezetimibe ketone | 191330-56-0 | >98% | |
Ezetimibe ketone (EZM-K) is a phase-I metabolite of Ezetimibe. | ||||
| GC60241 | Melatonin D5 | 66521-38-8 | >98% | |
An internal standard for the quantification of melatonin | ||||
| GC60257 | MSC1094308 | 2219320-08-6 | >98.00% | |
MSC1094308 is a non-competitive and reversible VPS4B/p97 (VCP) (I/II type AAA ATPase) allosteric inhibitor, with IC50 values of 0.71 μM and 7.2 μM for VPS4B and p97, respectively. MSC1094308 inhibits the D2 ATPase activity by binding to a drugable hotspot of p97. MSC1094308 can be used in study of cancer. | ||||
| GC60325 | Rilmenidine | 54187-04-1 | >98% | |
An antihypertensive agent | ||||
| GC60395 | (3S,5R)-Fluvastatin D6 | 2249799-34-4 | >98% | |
(3S,5R)-Fluvastatin D6 is the deuterium labeled (3S,5R)-Fluvastatin sodium. | ||||
| GC60567 | Afatinib impurity 11 | 1402086-20-7 | >99.00% | |
Afatinib impurity 11 is an impurity of Afatinib. Afatinib is an irreversible EGFR family inhibitor with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. | ||||
| GC60668 | Calcimycin hemimagnesium | 72124-77-7 | >98% | |
Calcimycin (A-23187) hemimagnesium is an antibiotic and a unique divalent cation ionophore (like calcium and magnesium). | ||||
| GC60688 | Cereblon modulator 1 | 1860875-51-9 | >99.50% | |
Cereblon modulator 1 (CC-90009) is a first-in-class GSPT1-selective cereblon (CRBN) E3 ligase modulator, acts as a molecular glue. | ||||
| GC60700 | Chloroquine D5 | 1854126-41-2 | >98% | |
Chloroquine D5 is deuterium labeled Chloroquine. | ||||
| GC60826 | Etoposide phosphate | 117091-64-2 | >96.00% | |
Etoposide phosphate (BMY-40481) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor?to prevent re-ligation of DNA strands. | ||||
| GC60868 | Gefitinib D8 | 857091-32-8 | >98.00% | |
Gefitinib D8 (ZD1839 D8) is a deuterium labeled Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells. | ||||
| GC60882 | Glyphosate | 1071-83-6 | ≥99.00% | |
An herbicide | ||||
| GC60891 | GW406108X | 1644443-92-4 | >98.00% | |
GW406108X is a specific Kif15 (Kinesin-12) inhibitor with an IC50 of 0.82 uM in ATPase assays. GW406108X, a potent autophagy inhibitor, shows ATP competitive inhibition against ULK1 with a pIC50 of 6.37 (427 nM). GW406108X inhibits ULK1 kinase activity and blocks autophagic flux, without affecting the upstream signaling kinases mTORC1 and AMPK. | ||||
| GC60930 | Imatinib D4 | 1134803-16-9 | >98% | |
Imatinib D4 (STI571 D4) is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. | ||||
| GC60935 | Indomethacin sodium hydrate | 74252-25-8 | >98.00% | |
Indomethacin (Indometacin) sodium hydrateis a potent, orally active COX1/2 inhibitor with IC50 values of 18 nM and 26 nM for COX-1 and COX-2, respectively. | ||||
| GC61003 | Loperamide D6 hydrochloride | 1189469-46-2 | >98% | |
Loperamide D6 hydrochloride (R-18553 D6 hydrochloride) is a deuterium labeled Loperamide hydrochloride. | ||||
| GC61045 | Metformin D6 hydrochloride | 1185166-01-1 | >98.00% | |
An internal standard for the quantification of metformin | ||||
| GC61093 | MSAB | 173436-66-3 | >99.00% | |
MSAB (methyl 3-{[(4-methylphenyl)sulfonyl]amino}benzoate) is a selective Wnt/β-catenin signaling inhibitor binding to β-catenin and promoting its degradation with an EC 50 of 0.583μM. | ||||
| GC61155 | Omeprazole sodium | 95510-70-6 | >98.00% | |
Omeprazole sodium (H 16868 sodium), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders. | ||||
| GC61183 | Physalin B | 23133-56-4 | >98% | |
Physalin B, one of the major active steroidal constituents of Cape gooseberry, induces cell cycle arrest and triggers apoptosis in breast cancer cells through modulating p53-dependent apoptotic pathway. Physalin B inhibits the ubiquitin-proteasome pathway and induces incomplete autophagic response in human colon cancer cells in vitro. | ||||
| GC61221 | PTP1B-IN-9 | 145888-79-5 | >98.00% | |
PTP1B-IN-9 is a ubiquitin-proteasome system (UPS)-stressor. PTP1B-IN-9 inhibits ubiquitin-mediated protein degradation upstream of the 20S proteasomal catalytic activites. PTP1B-IN-9 triggers a ubiquitin-proteasome-system (UPS)-stress response without affecting 20S proteasome catalytic activities. Anticancer activity. | ||||
